SCHEMBL1506284

SCHEMBL1506284

CCN(CC)CC.O=P(O)(O)[SeH]

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.42
MMP1 P03956 2/20 0.42
MMP2 P08253 2/20 0.42
MMP3 P08254 2/20 0.42
MMP8 P22894 2/20 0.42
CA2 P00918 1/20 0.33
PPIP5K2 O43314 1/20 0.33
LAP3 P28838 1/20 0.32
LMNA P02545 1/20 0.32
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
LPAR3 Q9UBY5 3/20 0.31
LPAR2 Q9HBW0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506279 1.00 FDPS (0.42) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL16093844 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL192006 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL21359160 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL9359318 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL28801115 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL192007 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL1019439 0.87 FDPS (0.46) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL23751823 0.84 FDPS (0.43) FDPSMMP1MMP2MMP3MMP8
Phosphoric Acid SCHEMBL8575235 0.84 FDPS (0.43) FDPSMMP1MMP2MMP3MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8519110-B2 mRNA cap analogs BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2013-08-27 US disclosed
EP-2297175-B1 MRNA CAP ANALOGS UNIV WARSZAWSKI (PL) 2013-08-07 EP disclosed
US-20110092574-A1 mRNA Cap Analogs NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-04-21 US disclosed
EP-2297175-A2 MRNA CAP ANALOGS Uniwersytet Warszawski (PL) 2011-03-23 EP disclosed
WO-2009149253-A2 MRNA CAP ANALOGS UNIWERSYTET WARSZAWSKI (PL) 2009-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092574-A1 mRNA Cap Analogs RNMT, RNGTT, NSUN2 FDPS 1289/4885MMP1 4873/4885MMP2 4805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.